Japan Clinical Oncology Group   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Tokyo Japan (1978)

Organization Overview

First Clinical Trial
1993
NCT00147147
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Haruhiko Fukuda | Japan Clinical Oncology Group